Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation

This study is currently recruiting participants.

Verified by Mayo Clinic, September 2005

Sponsors and Collaborators:	Mayo Clinic Hoffmann-La Roche
Information provided by:	Mayo Clinic
ClinicalTrials.gov Identifier:	NCT00170170

Purpose

This study will investigate the clinical variables that may be used to predict who among the solid organ transplant recipients will develop cytomegalovirus (CMV) disease after completing antiviral prophylaxis.

Condition
Transplantation Infection Cytomegalovirus Infections

MedlinePlus related topics: Cytomegalovirus Infections

U.S. FDA Resources

Study Type:	Observational
Study Design:	Natural History, Cross-Sectional, Defined Population, Retrospective Study
Official Title:	Clinical Predictors of Late-Onset CMV Disease in Solid Organ Transplant Recipients: A Strategy to Improve the Benefits and Reduce the Risks of Anti-CMV Prophylaxis

Further study details as provided by Mayo Clinic:

Estimated Enrollment:	500
Study Start Date:	November 2004

Detailed Description:

This study will investigate the clinical and laboratory variables that may be used to predict who among the solid organ transplant recipients will develop CMV disease after completing antiviral prophylaxis. This is a retrospective study of patients seen at the Mayo Clinic during the past five years.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Recipients of liver, kidney, pancreas, heart or lung transplantation

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00170170

Locations

United States, Minnesota
Mayo Clinic	Recruiting
Rochester, Minnesota, United States, 55905
Contact: Raymund R. Razonable 507-284-3747 razonable.raymund@mayo.edu
Principal Investigator: Raymund R. Razonable, M.D.

Sponsors and Collaborators

Mayo Clinic

Hoffmann-La Roche

Investigators

Principal Investigator:

Raymund R. Razonable, M.D.

Mayo Clinic

More Information

Study ID Numbers:	2275-04, VAL101
Study First Received:	September 13, 2005
Last Updated:	March 28, 2006
ClinicalTrials.gov Identifier:	NCT00170170
Health Authority:	United States: Institutional Review Board

Keywords provided by Mayo Clinic:

cytomegalovirus

Study placed in the following topic categories:

Virus Diseases
Cytomegalovirus Infections
DNA Virus Infections

Cytomegalic inclusion disease
Cytomegalovirus
Herpesviridae Infections

Additional relevant MeSH terms:

Communicable Diseases
Infection

ClinicalTrials.gov processed this record on January 16, 2009